News Image

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology

Provided By PR Newswire

Last update: Dec 11, 2025

MINNEAPOLIS, Dec. 11, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced a strategic collaboration between one of its spatial biology brands, Lunaphore, and the Wyss Center for Bio and Neuroengineering (Wyss Geneva) to develop an automated workflow for simultaneous RNA and protein detection in 3D specimens. The project will enable high-resolution multiomic analysis within intact 3D samples.

Read more at prnewswire.com

BIO-TECHNE CORP

NASDAQ:TECH (12/18/2025, 8:00:01 PM)

After market: 57.1 0 (0%)

57.1

+0.11 (+0.19%)



Find more stocks in the Stock Screener

TECH Latest News and Analysis

Follow ChartMill for more